AdaptHealth Reports Mixed 2025 Results Amid Strategic Investments
Event summary
- AdaptHealth reported a 0.5% decline in full-year 2025 net revenue to $3.24 billion, with a 1.7% organic revenue growth.
- Fourth-quarter 2025 net loss attributable to AdaptHealth was $102.8 million, compared to a net income of $50.3 million in the same period of 2024.
- The company reduced debt by $250 million in 2025 and received credit upgrades from S&P and Moody’s.
- AdaptHealth acquired a leading HME provider in Hawaii, expanding its operations to 48 states.
- The company provided 2026 financial guidance, projecting net revenue of $3.44 billion to $3.51 billion.
The big picture
AdaptHealth's 2025 results reflect a year of transition and strategic investments aimed at positioning the company for sustained growth. The acquisition in Hawaii and the largest capitated contract in the industry's history are key moves in a competitive healthcare-at-home market. The company's ability to balance these investments with financial discipline will be critical in the coming year.
What we're watching
- Execution Risk
- How AdaptHealth will manage the integration of its new capitated contract and strategic investments to achieve projected 2026 financial performance.
- Market Expansion
- Whether the acquisition in Hawaii will drive significant growth in the company's geographic footprint and patient base.
- Financial Health
- The pace at which AdaptHealth can sustain its debt reduction efforts while maintaining operational efficiency.
Related topics